1887.3000 -17.10 (-0.90%)
NSE May 11, 2026 09:47 AM
Volume: 23,422
 

1887.30
-0.90%
Axis Direct
we maintain our HOLD rating with a target price of 1,760, implying an upside potential of ~9.4%, valuing the company at a PE of 26x for FY26.
Gland Pharma Ltd. has an average target of 2165.00 from 3 brokers.
More from Gland Pharma Ltd.
Recommended